Dogwood Therapeutics (DWTX) Cash & Equivalents (2020 - 2026)
Dogwood Therapeutics (DWTX) reported Cash & Equivalents of $9.61 million for Q2 2026, down 28.3% from $13.4 million a year earlier and down 27.3% from the prior quarter.
Powered by 
Analysis
Dogwood Therapeutics (DWTX) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Dogwood Therapeutics posted Cash & Equivalents of $6.52 million, down 56.1% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -26.2% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $14.85 million in FY2024 (+347.6%), $3.32 million in FY2023 (-52.8%), $7.03 million in FY2022 (-49.8%) and $14.01 million in FY2021 (-53.0%).
- Five-year quarterly Cash & Equivalents spans a low of $2.04 million in Q3 2024 and a high of $19.19 million in Q3 2021.
- Year over year, Cash & Equivalents has now declined in each of the last three quarters, with growth averaging 194.8% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2025 (growth of 637.1%); the low point was Q2 2022 (a decline of 64.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $13.23 million (Q1 2026), $6.52 million (Q4 2025) and $10.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Dogwood Therapeutics | 38.91 Mn | -581,636.07 | - | 9.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.61 Mn |
| Mar 31, 2026 | 13.23 Mn |
| Dec 31, 2025 | 6.52 Mn |
| Sep 30, 2025 | 10.13 Mn |
| Jun 30, 2025 | 13.40 Mn |
| Mar 31, 2025 | 17.54 Mn |
| Dec 31, 2024 | 14.85 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 3.02 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | 3.32 Mn |
| Sep 30, 2023 | 4.79 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 5.33 Mn |
| Dec 31, 2022 | 7.03 Mn |
| Sep 30, 2022 | 9.79 Mn |
| Jun 30, 2022 | 7.70 Mn |
| Mar 31, 2022 | 11.35 Mn |
| Dec 31, 2021 | 14.01 Mn |
| Sep 30, 2021 | 19.19 Mn |
API Access
Dogwood Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DWTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "DWTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DWTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();